Olanzapine News and Research

RSS
Olanzapine (trade names Zyprexa, Zyprexa Zydis, Zalasta, Zolafren, Olzapin, Rexapin or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of schizophrenia and bipolar disorder.
Treatment of children and adolescents with schizophrenia

Treatment of children and adolescents with schizophrenia

New schizophrenia treatment

New schizophrenia treatment

Novel and inexpensive tool for identifying early signs of schizophrenia

Novel and inexpensive tool for identifying early signs of schizophrenia

Little evidence to support therapies for post-traumatic stress disorder

Little evidence to support therapies for post-traumatic stress disorder

Review of PTSD treatments

Review of PTSD treatments

Urgent need for better understanding of bipolar disease in children and adolescents

Urgent need for better understanding of bipolar disease in children and adolescents

New and very different schizophrenia drug shows promise

New and very different schizophrenia drug shows promise

New treatments for migraines and chronic headaches

New treatments for migraines and chronic headaches

Chemical maps hint at drug's effects on schizophrenia

Chemical maps hint at drug's effects on schizophrenia

Lilly to extend patient assistance programs for Medicare patients

Lilly to extend patient assistance programs for Medicare patients

Olanzapine appears to lower or delay full-blown psychosis

Olanzapine appears to lower or delay full-blown psychosis

Genes play a key role in stress response

Genes play a key role in stress response

Study of the effects of aripiprazole, olanzapine, quetiapine and risperidone, in elderly patients with dementia

Study of the effects of aripiprazole, olanzapine, quetiapine and risperidone, in elderly patients with dementia

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

New study details side effects of five medications that are currently used to treat people with schizophrenia

New study details side effects of five medications that are currently used to treat people with schizophrenia

FDA issues public health advisory for antipsychotic drugs

FDA issues public health advisory for antipsychotic drugs

FDA wants warnings put on antipsychotic drugs

FDA wants warnings put on antipsychotic drugs

New antipsychotic drug prevents brain loss in schizophrenia

New antipsychotic drug prevents brain loss in schizophrenia

Different antipsychotic medications may have different effects on brain volume in patients with first episode of psychosis

Different antipsychotic medications may have different effects on brain volume in patients with first episode of psychosis

Quetiapine speeds up rate of decline in Alzheimers

Quetiapine speeds up rate of decline in Alzheimers